期刊文献+

黄芩苷脂质体的制备及在小鼠体内的分布 被引量:9

Study on preparation of baicalin liposome and its tissue distribution in mice
暂未订购
导出
摘要 目的制备黄芩苷脂质体并考察其在小鼠体内的分布 ,为黄芩苷脂质体治疗乙型肝炎提供依据。方法用逆相蒸发法制备黄芩苷脂质体 ,测定其粒径及包封率 ,观察静脉注射黄芩苷脂质体及黄芩苷水溶液后 ,不同时间在小鼠体内的分布。结果 5批黄芩苷脂质体平均粒径为 (36 0± 4 2 )nm ,平均包封率为 (5 6 .0± 5 .3) %。黄芩苷脂质体主要分布于肝、脾 ,以肝脏中分布最多 ,而在血中清除加快。结论逆相蒸发法制备黄芩苷脂质体条件易控制 ,重复性好 ,可获得较高包封率和符合肝靶向要求的脂质体 ;黄芩苷脂质体具有一定的肝靶向性 ,可延缓黄芩苷在体内的代谢为乙肝治疗提供新途径。 PurposeTo investigate the preparation of baicalin liposome and to observe its tissue distribution in mice.MethodsBacalin liposome was prepared by reverse-phase evaporation; The diameter and entrapment efficiency (EC)of bacalin liposome were determined. Baicalin liposome distribution in mice tissue was determined by UV.ResultsThe main diameter and EC of baicalin liposomes were (360±42)nm and (56.02±5.3)%. Bacalin liposomes were found to be mainly distributed in liver and spleen. Blood clearance of baicalin liposomes was higher than that of baicalin solution.ConclusionReverse-phase evaporation method of baicalin liposomes preparation is simple and efficient. Baicalin liposome has liver-targeting properties and may provide a new application foreground for the treatment of virulent hepatitis.
出处 《中国生化药物杂志》 CAS CSCD 2004年第5期282-283,共2页 Chinese Journal of Biochemical Pharmaceutics
基金 陕西省科学技术研究发展计划项目 (No .2 0 0 2K11 G8)
关键词 脂质体 黄芩苷 肝靶向性 组织分布 liposome baicalin liver-targeting tissue distribution
  • 相关文献

参考文献4

二级参考文献18

  • 1裴瑾,吕延成,杨翰仪.白细胞介素2(IL—2)脂质体的制备及其包封率测定[J].白求恩医科大学学报,1996,22(3):319-320. 被引量:6
  • 2Higuchi M, Fokin A, Masters TN, et al. Transport of colloidal particlas in lymphatics and vasculature after subcutaneous injection[ J ]. J Appl Physiol, 1999, 86:1381-1387.
  • 3Oussoren C, Velinova M, Scherphof G, et al. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. IV. Fate of liposomesin regional lymph nodes[J]. Biochim Biophys Aeta, 1998,1370:259-272.
  • 4Bethune C, Blum A, Geyer JR, et al. Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea ( CCNU ) in rats [ J ].Pharm Res, 1999, 16:896-903.
  • 5Mercadal M, Domingo JC, Petriz J, et al. A novel strategy affords high-yield coupling of antibody to extremities of liposomal surface-gaffed PEG chains[J]. Biochim Biophys Acta, 1999, 1418:232-238.
  • 6Versluis AJ, Rump ET, Rensen PC, et al. Synthesis of a lipophilic daunoruvicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy[J]. Pharm Res, 1998,15:531-537.
  • 7Gabizon A, Horowitz AT, Goren D, et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies[J]. Bioconjug Chem, 1999, 10:289-298.
  • 8Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs[J]. Curr Pharm Des, 1999, 5:443-451.
  • 9Ogawa Y, Kawahara H, Yagi N, et al, Synthesis of a novel lipopeptide with alpha-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability[J]. Lipids, 1999, 34:387-394.
  • 10Krebber A, Bomhauser S, Burmester J, et al. Reliable cloning of functional antibody variable domains from hybfidoraas and spleen cell repertoires employing a reengineered phage display system[J]. J Immunol Methods, 1997, 201:35-55.

共引文献24

同被引文献150

引证文献9

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部